美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kyntra Bio Inc

7.96

-0.0250-0.31%

成交量：3.52萬

成交額：27.97萬

市值：3,218.15萬

市盈率：0.18

高：8.05

開：8.00

低：7.77

收：7.98

52周最高：12.60

52周最低：6.32

股本：404.54萬

流通股本：356.12萬

量比：1.66

換手率：0.99%

股息：- -

股息率：- -

每股收益(TTM):45.27

每股收益(LYR):45.37

淨資產收益率：--

總資產收益率：-22.50%

市淨率：-1.07

市盈率(LYR):0.18

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Kyntra Bio發布羅沙司他新數據：無論環狀鐵粒幼細胞狀態如何，均能改善低危MDS貧血患者輸血獨立性

Kyntra Bio公布FG-3246聯合恩雜魯胺治療轉移性去勢抵抗性前列腺癌的研究者發起1B/2期研究積極數據，將於2026年ASCO GU大會展示

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/KYNB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYNB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","market":"US","secType":"STK","nameCN":"Kyntra Bio Inc","latestPrice":7.955,"timestamp":1787684647847,"preClose":7.98,"halted":0,"volume":35172,"delay":0,"changeRate":-0.0031328320802005457,"floatShares":3561200,"shares":4045445,"eps":45.266125,"marketStatus":"交易中","change":-0.025,"latestTime":"08-25 15:07:37 EDT","open":8,"high":8.05,"low":7.77,"amount":279669.173184,"amplitude":0.035088,"askPrice":8.09,"askSize":300,"bidPrice":7.82,"bidSize":380,"shortable":3,"etf":0,"ttmEps":45.266125,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1415941200000,"exchange":"NASDAQ","adjPreClose":7.98,"postHourTrading":{"tag":"盘后","latestPrice":7.98,"preClose":7.98,"latestTime":"19:30 EDT","volume":162,"amount":1288.47,"timestamp":1787614203246,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.661348},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","floatShares":3561200,"roa":"-22.50%","roe":"--","lyrEps":45.371456,"volumeRatio":1.661348,"shares":4045445,"dividePrice":0,"high":8.05,"amplitude":0.035088,"preClose":7.98,"low":7.77,"week52Low":6.32,"pbRate":"-1.07","psRate":"6.97","week52High":12.6,"institutionHeld":0,"latestPrice":7.955,"committee":0.117647,"eps":45.266125,"divideRate":0,"volume":35172,"delay":0,"ttmEps":45.266125,"open":8,"prevYearClose":8.78,"prevWeekClose":7.52,"prevMonthClose":6.73,"prevQuarterClose":7.55,"fiveDayClose":7.01,"twentyDayClose":6.975,"sixtyDayClose":6.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYNB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"KYNB","fiscalQuarterEnding":"2026/06","expectedEps":-3.18,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-4.68},{"market":"US","date":"2026-05-11","symbol":"KYNB","fiscalQuarterEnding":"2026/03","expectedEps":-3.36,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-3.74},{"market":"US","date":"2026-03-16","symbol":"KYNB","fiscalQuarterEnding":"2025/12","expectedEps":-3.89,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"post","actualEps":-3.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYNB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYNB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1783569600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYNB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYNB","date":"2026-08-24","current":0.17121,"percent":0.56129,"low":0.128311,"twenty":0.149783,"median":0.16255,"eighty":0.173439,"high":0.188779,"avg":0.16144,"sd":0.014696,"marketCap":30449412},"quantilePoints":[{"date":"2026-01-09","current":0.17821,"twenty":0.178998,"median":0.18018,"eighty":0.181362,"marketCap":38431727},{"date":"2026-01-16","current":0.170144,"twenty":0.170369,"median":0.172958,"eighty":0.17821,"marketCap":36692186},{"date":"2026-01-23","current":0.168268,"twenty":0.168268,"median":0.171269,"eighty":0.17821,"marketCap":36287641},{"date":"2026-01-30","current":0.150259,"twenty":0.160389,"median":0.169206,"eighty":0.172958,"marketCap":32404014},{"date":"2026-02-06","current":0.140692,"twenty":0.153073,"median":0.163953,"eighty":0.171457,"marketCap":30340837},{"date":"2026-02-13","current":0.140317,"twenty":0.147445,"median":0.160201,"eighty":0.171269,"marketCap":30259928},{"date":"2026-02-20","current":0.14707,"twenty":0.146282,"median":0.158795,"eighty":0.170369,"marketCap":31716288},{"date":"2026-02-27","current":0.13075,"twenty":0.144894,"median":0.154199,"eighty":0.170144,"marketCap":28196751},{"date":"2026-03-06","current":0.129155,"twenty":0.137315,"median":0.150635,"eighty":0.168643,"marketCap":27852888},{"date":"2026-03-13","current":0.131688,"twenty":0.133714,"median":0.147445,"eighty":0.165191,"marketCap":28399023},{"date":"2026-03-20","current":0.161033,"twenty":0.133301,"median":0.147633,"eighty":0.164047,"marketCap":29541837},{"date":"2026-03-27","current":0.144268,"twenty":0.133714,"median":0.1489,"eighty":0.163953,"marketCap":26466248},{"date":"2026-04-02","current":0.156621,"twenty":0.135327,"median":0.1489,"eighty":0.163094,"marketCap":28732471},{"date":"2026-04-10","current":0.158607,"twenty":0.13649,"median":0.150021,"eighty":0.161629,"marketCap":29096686},{"date":"2026-04-17","current":0.158607,"twenty":0.137128,"median":0.152651,"eighty":0.161629,"marketCap":29096686},{"date":"2026-04-24","current":0.154658,"twenty":0.137616,"median":0.154087,"eighty":0.16165,"marketCap":28372304},{"date":"2026-05-01","current":0.160371,"twenty":0.138929,"median":0.154658,"eighty":0.161209,"marketCap":29420432},{"date":"2026-05-08","current":0.156671,"twenty":0.140092,"median":0.155492,"eighty":0.161033,"marketCap":28741595},{"date":"2026-05-15","current":0.173439,"twenty":0.140542,"median":0.155518,"eighty":0.16165,"marketCap":28377265},{"date":"2026-05-22","current":0.171707,"twenty":0.141779,"median":0.155761,"eighty":0.163953,"marketCap":28093897},{"date":"2026-05-29","current":0.173687,"twenty":0.143209,"median":0.156128,"eighty":0.168258,"marketCap":28417746},{"date":"2026-06-05","current":0.168491,"twenty":0.144709,"median":0.156621,"eighty":0.168887,"marketCap":27567642},{"date":"2026-06-12","current":0.167254,"twenty":0.145601,"median":0.156867,"eighty":0.168639,"marketCap":27365237},{"date":"2026-06-18","current":0.170965,"twenty":0.145982,"median":0.157197,"eighty":0.169431,"marketCap":27972453},{"date":"2026-06-26","current":0.171707,"twenty":0.14617,"median":0.158138,"eighty":0.170144,"marketCap":28093897},{"date":"2026-07-02","current":0.1868,"twenty":0.14632,"median":0.158607,"eighty":0.170718,"marketCap":30563245},{"date":"2026-07-10","current":0.181109,"twenty":0.146883,"median":0.158743,"eighty":0.171457,"marketCap":29632179},{"date":"2026-07-17","current":0.182841,"twenty":0.14707,"median":0.160014,"eighty":0.171955,"marketCap":29915547},{"date":"2026-07-24","current":0.174924,"twenty":0.147445,"median":0.160711,"eighty":0.173192,"marketCap":28620151},{"date":"2026-07-31","current":0.167996,"twenty":0.147746,"median":0.161253,"eighty":0.173241,"marketCap":27486680},{"date":"2026-08-07","current":0.172709,"twenty":0.148684,"median":0.162522,"eighty":0.173005,"marketCap":28257845},{"date":"2026-08-14","current":0.174182,"twenty":0.14943,"median":0.163953,"eighty":0.173489,"marketCap":28498708},{"date":"2026-08-21","current":0.161795,"twenty":0.149739,"median":0.162522,"eighty":0.173439,"marketCap":29639587},{"date":"2026-08-24","current":0.166216,"twenty":0.149783,"median":0.16255,"eighty":0.173439,"marketCap":30449412}],"updateTime":1787675080630},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYNB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1192420942","title":"Kyntra Bio發布羅沙司他新數據：無論環狀鐵粒幼細胞狀態如何，均能改善低危MDS貧血患者輸血獨立性","url":"https://stock-news.laohu8.com/highlight/detail?id=1192420942","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192420942?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 04:06","pubTimestamp":1781208416,"startTime":"0","endTime":"0","summary":"Kyntra Bio Inc公布了其药物罗沙司他的最新研究数据。数据显示，对于因低危骨髓增生异常综合征导致贫血的患者，无论其环状铁粒幼细胞状态如何，罗沙司他治疗均能显著改善患者的输血独立性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173376495","title":"Kyntra Bio公布FG-3246聯合恩雜魯胺治療轉移性去勢抵抗性前列腺癌的研究者發起1B/2期研究積極數據，將於2026年ASCO GU大會展示","url":"https://stock-news.laohu8.com/highlight/detail?id=1173376495","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173376495?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 06:11","pubTimestamp":1771884675,"startTime":"0","endTime":"0","summary":"Kyntra Bio公司宣布，其FG-3246与恩杂鲁胺联合用药方案针对转移性去势抵抗性前列腺癌患者的临床研究取得积极进展。这项由研究者发起的1B/2期试验数据显示出显著治疗潜力，相关完整数据报告已获选将于2026年美国临床肿瘤学会泌尿生殖系统肿瘤研讨会进行正式发布。\n该研究聚焦于晚期前列腺癌治疗领域的前沿探索，通过双药联用策略旨在突破现有治疗方案瓶颈。试验结果不仅验证了联合用药的安全性特征，更展现出令人鼓舞的疗效信号，为转移性去势抵抗性前列腺癌患者提供了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/KYNB\",params:#limit:6,delay:false,,,undefined,":[]}}